This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lopez, C. A. Articles by Weinstein, I. B. Search for Related Content PubMed PubMed Citation Articles by Lopez, C. A. Articles by Weinstein, I. B.

Effects of Triiodothyronine and Tamoxifen on Cell Transformation Induced by an Activated c-Ha-ras Oncogene¹

Comprehensive Cancer Center [C. A. L., W-L. W. H., I. B. W.], Institute of Cancer Research [C. A. L., W-L. W. H., I. B. W.], and Departments of Pathology [C. A. L.] and Medicine [I. B. W.], Columbia University, New York, New York 10032

We have found that the thyroid hormone 3,5',3'-triiodo-L-thyronine stimulates the transformation of Rat 6 fibroblasts when these cells are transfected with an activated human c-Ha-ras oncogene (T24). 3,5',3'-Triiodo-L-thyronine did not further augment the stimulation of oncogene-induced transformation obtained with a phorbol ester tumor promoter (12-O-tetradecanoylphorbol-13-acetate) or a factor from fetal calf serum. On the other hand, tamoxifen, an antiestrogen that also inhibits protein kinase C, markedly inhibited Ha-ras-induced cell transformation in the presence of 12-O-tetradecanoylphorbol-13-acetate or fetal calf serum. Time course studies and Southern blot analyses of DNAs isolated from transformed foci provided evidence that 3,5',3'-triiodo-L-thyronine and tamoxifen do not exert their effects simply by enhancing or inhibiting integration of the transfected oncogene into cellular DNA. These findings indicate that hormonal factors can modulate the ability of an activated Ha-ras oncogene to transform cells. They may be relevant to the process of multistage carcinogenesis in vivo.

¹ This research was supported by National Cancer Institute Grant 06265 to I. B. W.

Received 7/15/88. Revised 10/17/88. Accepted 11/11/88.

This article has been cited by other articles:

				W. L. W. Hsiao, Y. Q. Li, T. L. Lee, N. Li, M. M. You, and S.-t. Chang Medicinal mushroom extracts inhibit ras-induced cell transformation and the inhibitory effect requires the presence of normal cells Carcinogenesis, July 1, 2004; 25(7): 1177 - 1183. [Abstract] [Full Text] [PDF]